Latest filingSep 02, 2026Most recent Form 4
GILD
GILEAD SCIENCES, INC.
NasdaqHealthcareBiological Products, (No Diagnostic Substances)
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$989M15 sells
Net open-market-$989M5 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period30transactions
- M · Option exercise · dominant15 · 50%
- S · Open-market sells15 · 50%
Activity by reported role
A joint filing can contribute to multiple roles39transactions
- Director · dominant20 · 51%
- CAO6 · 15%
- CC6 · 15%
- Chief executive officer3 · 8%
- CHAIR3 · 8%
- Chief financial officer1 · 3%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (4)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeBluestone JeffreyCommon Stock · Direct
10,066Aug 20, 2026
Welters AnthonyCommon Stock · Direct
23,176Aug 26, 2026
Mercier JohannaCommon Stock · Direct
129,704Aug 17, 2026
O'Day Daniel PatrickCommon Stock · Direct
590,533Sep 01, 2026
Mercier JohannaNon-qualified Stock Option (Right to Buy) · Direct
69,960Aug 17, 2026
Bluestone JeffreyNon-qualified Stock Option (Right to Buy) · Direct
0Aug 20, 2026
Welters AnthonyNon-qualified Stock Option (Right to Buy) · Direct
5,569Aug 26, 2026
Dickinson Andrew DCommon Stock · Direct
165,646Aug 17, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
GILD transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
No transactions match your filtersOnce the backend ingests and parses SEC filings, they will appear here. Try removing a filter or picking a wider date range. | ||||||||||
GILEAD SCIENCES, INC. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at GILEAD SCIENCES, INC.?
O'Day Daniel Patrick, WELTERS ANTHONY, Bluestone Jeffrey, Dickinson Andrew D, Mercier Johanna.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
O'Day Daniel Patrick reported a sale on Sep 01, 2026 valued at $80.7M. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $9,898,877.58. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.